Dris El Atmioui
- Immunology top 2%
- Immunotherapy and Immune Responses 3
- Oncology top 2%
- Peptidase Inhibition and Analysis 7
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 2
-
- Ubiquitin and proteasome pathways 10
- Glycosylation and Glycoproteins Research 4
- Biochemical and Molecular Research 2
- Protein Degradation and Inhibitors 2
- Co-authors
- Henk HilkmannTon N. SchumacherMarit M. van BuurenMichael R. StrattonSam BehjatiJohn B.A.G. HaanenArno VeldsHuib Ovaa
- Cited by
- ImmunologyOncologyMolecular Biology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Angewandte Chemie International Edition (2 papers)
- Partner nations
- NetherlandsUnited KingdomDenmark
In The Last Decade
Dris El Atmioui
13 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Immunology 970
- Oncology 1.1k
- Molecular Biology 661
- Cancer Research 124
- Radiology, Nuclear Medicine and Imaging 106
Countries citing papers authored by Dris El Atmioui
This map shows the geographic impact of Dris El Atmioui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dris El Atmioui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dris El Atmioui more than expected).
Fields of papers citing papers by Dris El Atmioui
This network shows the impact of papers produced by Dris El Atmioui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dris El Atmioui. The network helps show where Dris El Atmioui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dris El Atmioui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 7 | |
| 2 | 2018 | 43 | |
| 3 | 2018 | 49 | |
| 4 | 2018 | 28 | |
| 5 | 2018 | 12 | |
| 6 | 2018 | 5 | |
| 7 | 2017 | 124 | |
| 8 | 2016 | 0 | |
| 9 | High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanomabreakdown → | 2014 | 527 |
| 10 | 2013 | 43 | |
| 11 | Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanomabreakdown → | 2013 | 624 |
| 12 | 2012 | 63 | |
| 13 | 2012 | 13 | |
| 14 | 2012 | 9 |
About Dris El Atmioui
Dris El Atmioui is a scholar working on Oncology, Molecular Biology and Immunology, having authored 14 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Peptidase Inhibition and Analysis (7 papers), Glycosylation and Glycoproteins Research (4 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Biochemical and Molecular Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Immunology (970 citations), Oncology (1.1k citations) and Molecular Biology (661 citations). Dris El Atmioui has collaborated with scholars based in Netherlands, United Kingdom and Denmark. Frequent co-authors include Henk Hilkmann, Ton N. Schumacher, Marit M. van Buuren, Michael R. Stratton, Sam Behjati, John B.A.G. Haanen, Arno Velds, Huib Ovaa, Mireille Toebes and Bianca Heemskerk. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.